Jennifer Mannheim

Anti-inflammatory add-on treatment is beneficial for patients with major depressive disorder (MDD) or depressive symptoms.

The Food and Drug Administration (FDA) has granted Fast Track designation to nalmefene HCl injection (Purdue Pharma) for the emergency treatment of known or suspected opioid overdoses.

Cognitive delays and poor academic performance are negative outcomes associated with excessive screen time.

Trazodone is not associated with a reduced risk for dementia compared with other antidepressants at the prodromal stage of disease.

Since 1990, the age-standardized mortality rate for suicide has decreased worldwide.

Few adolescents meet sleep, physical activity, and screen-time guidelines concurrently.

The FDA has issued a Complete Response Letter to Alkermes regarding the New Drug Application for ALKS 5461, an investigational adjunctive treatment for major depressive disorder.

Physicians who receive direct pharmaceutical payments for opioid prescribing prescribe more opioids, especially hydrocodone and oxycodone.

Improving clinic capacity to respond to patients’ social needs may reduce primary care physician burnout.

More than two-thirds of stroke survivors aged 50 years or older report being in complete mental health.

A shortage of the anti-anxiety drug buspirone in the United States has patients and doctors concerned.

For internal medicine interns, depressive symptoms increase during internship, with poor faculty feedback and inpatient learning experience associated with increased depressive symptoms.

Adolescents with higher levels of conduct disorder symptoms and greater rates of depressive symptoms have increased odds of reporting participation in the choking game.

Outpatient benzodiazepine use increased from 2003 to 2015

Patients with a cancer diagnosis have an increased risk for suicide during the first year after their diagnosis compared with the general population, with higher suicide rates for cancers with a poor prognosis.

Therapists implementing interpersonal psychotherapy for depressed adolescents should routinely monitor depression symptoms and consider augmenting treatment for insufficient responders as early as week 4 of treatment.

Cancer patients have an increased suicide risk, which is predominant among men and white patients.

From 2007 to 2016, there was an increase in the proportion of substance use treatment facilities offering medication treatment.

Concurrent use of benzodiazepine receptor modulators and opioids and of nonselective and selective benzodiazepine receptor modulators increased from 1999-2000 to 2013-2014.